NRSN (STOCKS)

    NeuroSense Therapeutics Ltd. Ordinary Shares

    $0.980600
    -0.019400 (-1.94%)
    Prev close: $1.000000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Alon Ben-Noon
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $31.12M
    Employees
    15
    P/E (TTM)
    -1.78
    P/B (TTM)
    9.35
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    2
    Strong Buy
    6
    Buy
    2
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Dec 2024 (Q4)
    $-0.06 $-0.12 +0.0573 +48.85%
    Sep 2024 (Q3)
    $-0.11 $-0.16 +0.0532 +32.60%
    Jun 2024 (Q2)
    $-0.02 $-0.20 +0.1840 +90.20%
    Mar 2024 (Q1)
    $-0.35 $-0.21 -0.1409 -67.38%